Table 1.
Characteristics of Patients Whose Data Were Used in the Analysis
| hESC methylator-negative | hESC methylator-positive | Total | |
|---|---|---|---|
| No. of patients | 25 | 15 | 40 |
| TCGA patient phenotype | |||
| age, years | |||
| Median (LQ, UQ) | 56.3 (51.3, 67.0) | 32 (28.4, 38.8) | 53.6 (41.8, 58.3) |
| No. ≤40 years old | 1 | 12 | 13 |
| Survival (weeks) | |||
| Mediana (CI) | 44.0 (28.6, 50.7) | 141.0 (80.4, 325.1) | 60.5 (44.7, 90.0) |
| Sex | |||
| Female | 18 | 8 | 26 |
| Male | 7 | 7 | 14 |
CI, confidence interval; LQ, lower quartile; UQ, upper quartile.
a
Median survival and corresponding confidence intervals were estimated from the Kaplan-Meier curve